{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pre-conception-advice-management/management/genetic-risk-assessment/","result":{"pageContext":{"chapter":{"id":"06434a48-ae53-5381-a6e0-d1d478bf119e","slug":"genetic-risk-assessment","fullItemName":"Scenario: Genetic risk assessment","depth":2,"htmlHeader":"<!-- begin field f97af545-bbc8-4b8b-92f8-a7bc00a2ad27 --><h2>Scenario: Genetic risk assessment</h2><!-- end field f97af545-bbc8-4b8b-92f8-a7bc00a2ad27 -->","summary":"Covers the provision of advice about preliminary assessment of couples concerned about their risk of inherited genetic disorders in general practice, and information regarding who should be referred for further assessment and genetic screening.","htmlStringContent":"<!-- begin item b6189b02-bdb9-49cd-8aa4-a7bc00a2a75a --><!-- begin field 15ba2263-26c3-4fe3-8c97-acbd00863c8a --><p>From age 16 years to 45 years.</p><!-- end field 15ba2263-26c3-4fe3-8c97-acbd00863c8a --><!-- end item b6189b02-bdb9-49cd-8aa4-a7bc00a2a75a -->","topic":{"id":"7fbac536-1f76-5678-a8d3-791cde12bdcc","topicId":"362122fc-a8d4-48c6-bbe1-260b84fdc035","topicName":"Pre-conception - advice and management","slug":"pre-conception-advice-management","lastRevised":"Last revised in November 2019","chapters":[{"id":"b4e662d9-e04d-5220-9289-f9d2f83a655d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d516f1b7-0d03-56d1-a1ff-98ee4586d10c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"05f2e291-0cb3-508a-a53a-203bf7452154","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"eea0164e-7605-53f2-82b1-30649c6b462b","slug":"changes","fullItemName":"Changes"},{"id":"3107f6a6-010e-5793-b49e-f188321b5d25","slug":"update","fullItemName":"Update"}]},{"id":"ccdc8c20-befb-5b1b-9e44-e7d66512c304","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d2c77d6a-aa8b-5f5a-bc22-e802a1ed63dd","slug":"goals","fullItemName":"Goals"},{"id":"354ac657-195c-55c7-86dc-32bd495719e6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"90c0a8b7-d685-5b54-ab19-50262a840059","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8991e1d6-fe99-54e2-a7f0-8c087cbc913e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce6a54cd-7770-5f7d-b3d4-72d82e13e288","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cea8adf5-cc1a-59e9-b1bc-a7fe7dd9612e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ebfaff6-f12e-5e6d-a4da-824f9755cc22","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"eb257b56-0f26-5b88-b016-779a5c57372a","slug":"definition","fullItemName":"Definition"}]},{"id":"cb07c890-793e-585a-b84c-853632ed27ce","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd42d278-6050-5b5b-866a-cbfbf0423199","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"eb9c8dbd-e2aa-5e1d-ad75-0f16e58a1422","slug":"advice-for-all-women","fullItemName":"Scenario: Advice for all women"},{"id":"7e7545d6-d6f7-57bc-89ea-6441a4ec2db1","slug":"mental-health-problems","fullItemName":"Scenario: Mental health problems"},{"id":"1a2f1279-2d58-50c7-9319-7566398adf95","slug":"chronic-medical-conditions","fullItemName":"Scenario: Chronic medical conditions"},{"id":"06434a48-ae53-5381-a6e0-d1d478bf119e","slug":"genetic-risk-assessment","fullItemName":"Scenario: Genetic risk assessment"}]},{"id":"09ba2cc8-ed92-569e-8221-2fc8961a9165","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5d207bb7-2d21-5faf-8689-655bc58b847f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c10ffbd-047a-5920-9dc4-cfc597cebbad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aaed13a3-4796-527d-97c1-0d3f0522735c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d4f44dbc-1899-520a-af01-19a4c31b4859","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"78c00268-d8ca-507c-b64e-d937902ec290","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8a776444-784a-5839-9597-61faaeeb2101","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6a3cee62-2ded-5f48-b3fc-9b11a7a28a12","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cb07c890-793e-585a-b84c-853632ed27ce","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"14c905ed-141d-572c-bcbf-2ada18e640d0","slug":"risk-of-inherited-genetic-disorder","fullItemName":"Risk of inherited genetic disorder","depth":3,"htmlHeader":"<!-- begin field 068a81ed-237c-4e0f-8bd6-a7bc00a2ae29 --><h3>How should I assess and manage a couple's risk of having a baby with an inherited genetic disorder?</h3><!-- end field 068a81ed-237c-4e0f-8bd6-a7bc00a2ae29 -->","summary":null,"htmlStringContent":"<!-- begin item e8c4ea14-ffd4-4bca-b857-a7bc00a2ae29 --><!-- begin field 532b7a4b-b0cf-42d1-b6a9-a7bc00a2ae29 --><ul><li><strong>Take a history, to identify potential factors increasing genetic risks to a mother or baby. </strong>Enquire about:<ul><li>Family history of genetic conditions for the woman and, if possible, her partner (for example spinal muscular atrophy, cystic fibrosis, haemoglobinopathies, Fragile X syndrome, Tay-Sachs disease). </li><li>Ethnic background, for example: <ul><li>Cystic fibrosis is more common in people of Northern European descent.</li><li>Sickle cell disease is more common in people of African descent.</li><li>Alpha thalassaemia is more common in people of Southeast Asian, African, West Indian and Mediterranean descent.</li><li>Beta thalassaemia is more common in people of Mediterranean, Asian, Middle Eastern, Hispanic and West Indican descent.</li><li>Tay-Sachs disease is more common in people of Ashkenazi Jewish, French-Canadian, or Cajun descent. </li></ul></li><li>Consanguinity (the couple are second cousins or closer in family relationship).  </li><li>Obstetric history including pregnancy losses and congenital abnormalities.<strong> </strong></li></ul></li><li><strong>Seek specialist advice or consider referral to a healthcare provider with genetics expertise</strong> for couples with:<ul><li>A personal or family history of an inherited genetic disorder. </li><li>A previous pregnancy affected by an inherited genetic disorder. </li><li>Consanguinity. </li><li>Recurrent pregnancy losses. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/miscarriage/\">Miscarriage</a>. </li></ul></li></ul><!-- end field 532b7a4b-b0cf-42d1-b6a9-a7bc00a2ae29 --><!-- end item e8c4ea14-ffd4-4bca-b857-a7bc00a2ae29 -->","subChapters":[{"id":"521b1ef2-3306-5288-92bc-4fca01142dbd","slug":"basis-for-recommendation-c5b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8b0768d1-a8e8-43a0-9752-a7bc00a2ae2d --><h4>Basis for recommendation</h4><!-- end field 8b0768d1-a8e8-43a0-9752-a7bc00a2ae2d -->","summary":null,"htmlStringContent":"<!-- begin item c5bf01e2-4aef-415c-9e8f-a7bc00a2ae2d --><!-- begin field 5e37fa39-7927-4dda-99e5-a7bc00a2ae2d --><p>Ideally carrier screening and counselling should be performed before pregnancy, so couples are aware of their reproductive risk and are able to consider a greater range of options than if the woman is already pregnant [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">ACOG, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Ioannides, 2017</a>]. </p><h5>History</h5><ul><li>This recommendation is based on, and extrapolated from the American College of Obstetricians and Gynecologists (ACOG) Committee on Genetics opinion document on <em>Carrier screening for genetic conditions</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">ACOG, 2017a</a>],<strong> </strong>a Cochrane systematic review on <em>Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Hussein et al, 2015</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Ioannides, 2017</a>].</li></ul><h5>Seeking specialist advice or referring for risk assessment, evaluation, and consideration of diagnostic testing</h5><ul><li>CKS found no guidelines specifically relating to a primary care setting, but have extrapolated these recommendations from information in the ACOG Committee on Genetics opinion document on <em>Carrier screening for genetic conditions </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">ACOG, 2017a</a>] that recommends referral to an obstetrician-gynaecologist or other healthcare provider with genetic expertise for risk assessment, evaluation, and consideration of diagnostic testing for people with a family history of a genetic condition or for whom there is concern about a genetic diagnosis.</li><li>Seeking specialist advice or considering referral is also recommended because careful counselling is needed before undertaking testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Ioannides, 2017</a>]<strong> </strong>and the resources and expertise to do this may not be available in primary care.<ul><li>The ACOG also recommends genetic counselling for couples with consanguinity due to the increased risk of recessive conditions in their children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">ACOG, 2017b</a>].</li><li>The recommendation regarding couples with recurrent pregnancy losses is extrapolated from expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Ioannides, 2017</a>]. The Royal College of Obstetricians and Gynaecologists guideline on <em>The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage</em> recommends women who have experienced recurrent first-trimester or second-trimester miscarriage should be managed by a person with the necessary skills and expertise and offered referral to a specialist clinic. These women should have pre-conception screening for antiphospholipid antibodies (plus a screen for inherited thrombophilias for women with second-trimester miscarriage), but routine karyotyping of couples with recurrent miscarriage is not recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">RCOG, 2011b</a>].</li></ul></li></ul><!-- end field 5e37fa39-7927-4dda-99e5-a7bc00a2ae2d --><!-- end item c5bf01e2-4aef-415c-9e8f-a7bc00a2ae2d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}